logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
MNOV
MediciNova, Inc.
1.32
17 x 1.32
4 x 1.34
bid
ask
+
0.00
0.00%
01:27 PM
timesize
Ytd0.76%
1y-1.49%
1.32
day range
1.43
1.17
52 week range
1.96
Open1.43Prev Close1.32Low1.32High1.43Mkt Cap64.97M
Vol4.29KAvg Vol46.42KEPS-0.23P/E-5.74Forward P/E-0.06
Beta0.63Short Ratio11.20Inst. Own21.30%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg1.34200-d Avg1.431yr Est8.33

MNOV News

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
globenewswire.com
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program

LA JOLLA, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova CEO Provides Shareholder Update
globenewswire.com
MediciNova CEO Provides Shareholder Update

LA JOLLA, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
globenewswire.com
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with An

LA JOLLA, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
globenewswire.com
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of

LA JOLLA, Calif. , May 26, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc. , a biopharmaceutical company t

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
globenewswire.com
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medic

LA JOLLA, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company t

MediciNova (NASDAQ:MNOV) Shares Cross Above 200 Day Moving Average – Here’s What Happened
defenseworld.net
MediciNova (NASDAQ:MNOV) Shares Cross Above 200 Day Moving Average – Here’s What Happened

MediciNova, Inc. (NASDAQ: MNOV - Get Free Report) crossed above its 200-day moving average during tr

MediciNova to Participate at the 38th Annual ROTH Conference
globenewswire.com
MediciNova to Participate at the 38th Annual ROTH Conference

LA JOLLA, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company t

MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of “Moderate Buy” by Brokerages
defenseworld.net
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of MediciNova, Inc. (NASDAQ: MNOV - Get Free Report) have earned an average rating of "Modera

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
globenewswire.com
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating

LA JOLLA, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova, Inc. (NASDAQ:MNOV) Receives $7.00 Average Target Price from Analysts
defenseworld.net
MediciNova, Inc. (NASDAQ:MNOV) Receives $7.00 Average Target Price from Analysts

Shares of MediciNova, Inc. (NASDAQ: MNOV - Get Free Report) have received an average recommendation

VivoSim Labs (NASDAQ:VIVS) and MediciNova (NASDAQ:MNOV) Head-To-Head Analysis
defenseworld.net
VivoSim Labs (NASDAQ:VIVS) and MediciNova (NASDAQ:MNOV) Head-To-Head Analysis

MediciNova (NASDAQ: MNOV - Get Free Report) and VivoSim Labs (NASDAQ: VIVS - Get Free Report) are bo

2026 New Year's Greetings from the CEO
globenewswire.com
2026 New Year's Greetings from the CEO

LA JOLLA, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
globenewswire.com
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Preventio

LA JOLLA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
globenewswire.com
MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Tria

LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company li

MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
globenewswire.com
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor

LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
globenewswire.com
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awar

LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
globenewswire.com
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Pub

Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and

MediciNova to Present at the LD Micro Main Event XIX Investor Conference
globenewswire.com
MediciNova to Present at the LD Micro Main Event XIX Investor Conference

LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company tr

MediciNova Provides Shareholder Update on Key Developments
globenewswire.com
MediciNova Provides Shareholder Update on Key Developments

LA JOLLA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company t
benzinga.com
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving I
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  During Wednesday's trading, 517 companies set new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 838 companies hit new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 297 companies achieved new lows for the year.
benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday morning saw 454 companies set new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday
benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday
benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday
benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday
benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday
benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday
benzinga.com
30 Stocks Moving In Monday's Pre-Market Session

30 Stocks Moving In Monday's Pre-Market Session
benzinga.com
Earnings Scheduled For May 16 (VOXX, JCP, ALN, LOW, STV, WINN, SORL, GLPW, CTRP, URBN, JST, ZOOM, DL

Earnings Scheduled For May 16 (VOXX, JCP, ALN, LOW, STV, WINN, SORL, GLPW, CTRP, URBN, JST, ZOOM, DL